Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Clinical trials in Lafayette, LA: what is studied
Cancer. The Cancer Center of Acadiana and local urology practices take part in cancer studies, including prostate cancer and bladder cancer; see our oncology clinical trials page.
Digestive diseases. The Gastroenterology Clinic of Acadiana takes part in studies for Crohn's disease, ulcerative colitis, and other digestive conditions.
Vaccines and healthy volunteers. Vaccine studies recruit in Lafayette, and some local studies accept healthy volunteers. If you have never taken part in research, our guide explains how to volunteer for clinical trials.
Other conditions. Studies in heart disease, asthma, COPD, wound care, and weight loss also recruit in the area.
Paid clinical trials in Lafayette and Acadiana
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. Payments are reviewed by the institutional review board that oversees the study, and under FDA guidance they are usually paid out over the course of the study rather than only at the end. Many studies at least cover travel, which helps if you are coming from elsewhere in Acadiana.
Our guide explains how much clinical trials pay and how payment is decided.
Clinical trials in New Iberia, Eunice, and across Acadiana
Some studies recruit at research sites in smaller Acadiana towns such as New Iberia and Eunice, and studies at those sites appear on this page alongside those in Lafayette. For larger hospital programs, see our Baton Rouge page, about an hour east, and our New Orleans page, or browse all Louisiana clinical trials.
How to join a clinical trial in Lafayette
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as Crohn's disease or prostate cancer.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Lafayette or a nearby town such as New Iberia or Eunice.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Can I leave a clinical trial after I join?
Yes. Participation is voluntary, and you can leave a study at any time without affecting your regular medical care. The study team may ask you to come for a final safety visit. Our guide explains informed consent and your rights as a participant.